Free Trial
NYSE:GORO

Gold Resource (GORO) Stock Price, News & Analysis

$0.49
+0.01 (+2.21%)
(As of 09:46 AM ET)
Today's Range
$0.48
$0.49
50-Day Range
$0.38
$0.55
52-Week Range
$0.22
$0.71
Volume
108,145 shs
Average Volume
682,734 shs
Market Capitalization
$44.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
GORO stock logo

About Gold Resource Stock (NYSE:GORO)

Gold Resource Corporation engages in the exploration, development, and production of gold and silver projects in Mexico and the United States. The company also explores for copper, lead, and zinc deposits. Its principal assets are the 100% owned Don David gold mine and Back Forty project covering approximately 1,304 hectares located in Menominee county, Michigan. The company was incorporated in 1998 and is headquartered in Denver, Colorado.

GORO Stock Price History

GORO Stock News Headlines

Does this make you sick?
The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.
This $0.30 AI Stock Could Revolutionize Public Safety
This AI security pioneer saw a 128% revenue surge in 2023, hitting $12.8 million. Yet it has a market cap of just $35 million. Here's the kicker: The security robots market is projected to reach $120 billion by 2030.
Gold Resource Corporation (GORO)
Best Gold IRA Companies of May 2024
Gold Resource earnings: here's what to expect
KALMF Kalgoorlie Gold Mining Limited
See More Headlines
Receive GORO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gold Resource and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/02/2024
Today
7/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Gold & silver ores
Sub-Industry
N/A
Employees
504
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.50
High Stock Price Target
$1.50
Low Stock Price Target
$1.50
Potential Upside/Downside
+212.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-16,020,000.00
Pretax Margin
-31.09%

Debt

Sales & Book Value

Annual Sales
$85.20 million
Cash Flow
$0.12 per share
Book Value
$1.09 per share

Miscellaneous

Free Float
88,340,000
Market Cap
$43.53 million
Optionable
Optionable
Beta
1.46
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Allen Joseph Palmiere B. Comm. (Age 71)
    B.Com., C.A., CEO, President & Director
    Comp: $495k
  • Mr. Chet Holyoak (Age 43)
    CFO & Corporate Controller
    Comp: $217.29k
  • Mr. Alberto Reyes B.E. (Age 48)
    Chief Operating Officer
    Comp: $391k
  • Mr. Patrick Frenette
    Vice President of Technical Services

GORO Stock Analysis - Frequently Asked Questions

How have GORO shares performed this year?

Gold Resource's stock was trading at $0.2356 on January 1st, 2024. Since then, GORO stock has increased by 103.5% and is now trading at $0.4795.
View the best growth stocks for 2024 here
.

How were Gold Resource's earnings last quarter?

Gold Resource Co. (NYSE:GORO) released its earnings results on Thursday, May, 2nd. The company reported ($0.05) earnings per share for the quarter. The company had revenue of $18.70 million for the quarter. Gold Resource had a negative trailing twelve-month return on equity of 19.21% and a negative net margin of 22.30%.

How do I buy shares of Gold Resource?

Shares of GORO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Gold Resource own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gold Resource investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX) and Catalyst Pharmaceuticals (CPRX).

This page (NYSE:GORO) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners